TY - RPRT
T1 - EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to the raw fruit of Emblica officinalis Gaertn. and maintenance of normal blood LDL-cholesterol concentrations (ID 4041) and protection of DNA, proteins and lipids from oxidative damage (ID 4042) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
AU - EFSA Publication
AU - Tetens, Inge
PY - 2011
Y1 - 2011
N2 - Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked to provide a scientific opinion on a list of health claims pursuant to Article 13 of Regulation (EC) No 1924/2006. This opinion addresses the scientific substantiation of health claims in relation to the raw fruit of Emblica officinalis Gaertn. and maintenance of normal blood LDL-cholesterol concentrations and protection of DNA, proteins and lipids from oxidative damage. The scientific substantiation is based on the information provided by the Member States in the consolidated list of Article 13 health claims and references that EFSA has received from Member States or directly from stakeholders.
The food that is the subject of the health claims is “Emblica officinalis fruit rind”. From the references provided the Panel considers that the raw fruit of Emblica officinalis Gaertn. is sufficiently characterised in relation to the claimed effects.
AB - Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked to provide a scientific opinion on a list of health claims pursuant to Article 13 of Regulation (EC) No 1924/2006. This opinion addresses the scientific substantiation of health claims in relation to the raw fruit of Emblica officinalis Gaertn. and maintenance of normal blood LDL-cholesterol concentrations and protection of DNA, proteins and lipids from oxidative damage. The scientific substantiation is based on the information provided by the Member States in the consolidated list of Article 13 health claims and references that EFSA has received from Member States or directly from stakeholders.
The food that is the subject of the health claims is “Emblica officinalis fruit rind”. From the references provided the Panel considers that the raw fruit of Emblica officinalis Gaertn. is sufficiently characterised in relation to the claimed effects.
U2 - 10.2903/j.efsa.2011.2217
DO - 10.2903/j.efsa.2011.2217
M3 - Report
T3 - the EFSA Journal
BT - EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to the raw fruit of Emblica officinalis Gaertn. and maintenance of normal blood LDL-cholesterol concentrations (ID 4041) and protection of DNA, proteins and lipids from oxidative damage (ID 4042) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
PB - European Food Safety Authority
CY - Parma, Italy
ER -